24 Recent phylogenomic analyses have solved evolutionary relationships between most of the 25 Orchidaceae subfamilies and tribes, yet phylogenetic relationships remain unclear within the 26 42 43 45 46 47 100, PP = 0.77-1.0), and only a few positions remained unresolved. Here, the relationship between 128 Codonorchidae+Orchideae was moderately supported (LBS = 86) together with that of 129 Cymbidiinae and the remaining Cymbidieae (LBS = 62). The monophyly of Nervilieae and 130 Triphoreae was moderately supported (LBS = 79), as well as the phylogenetic relationships of 131 Nervilieae+Triphoreae and the remainder of Epidendroideae (LBS = 75), and Epidendreae and 132 Coelia + Eria (LBS = 52) (Fig. 2). 133 134 2.3 Molecular characterisation of plastid genomes 135 Whole plastome sequences belonging to 97 species (11 sequenced here and 86 reported in 136 NCBI) were annotated for 75 protein-coding genes. Five additional genes were recovered when 137 concatenating this data matrix with the protein coding regions matrix used by Givnish 2 , giving a 138 6

Fungi provide new opportunities to study highly differentiated mitochondrial DNA. Mycosphaerellaceae is a highly diverse fungal family containing a variety of pathogens affecting many economically important crops.Mitochondria plays a major role in fungal metabolism and fungicide resistance but up until now only two annotated mitochondrial genomes have been published in this family. We sequenced and annotated mitochondrial genomes of selected Mycosphaerellaceae species that diverged ~66 MYA. During this time frame, mitochondrial genomes expanded significantly due to at least five independent invasions of introns into different electron transport chain genes. Comparative analysis revealed high variability in size and gene order among mitochondrial genomes even of closely related organisms, truncated extra gene copies and, accessory genes in some species. Gene order variability was common probably due to rearrangements caused by mobile intron invasion. Three three cox1 copies and bicistronic transcription of nad2-nad3 and atp6-atp8 in Pseudocercospora fijiensis were confirmed experimentally.Even though we found variation in mitochondrial genome composition, there was no evidence of hybridization when comparing nuclear and mitochondrial dataset sets for fungal plant pathogens analyzed here. Disentangling the causes of variation in mitochondrial genome composition in plant pathogenic fungal move us closer to understanding the molecular mechanisms responsible for vital functions in fungi ultimately aiding in controlling these diseases.

Background: Dysbiosis of the microbiome has been related to the Celiac disease (CeD) progress, an autoimmune disease characterised by gluten intolerance developed in genetically susceptible individuals under certain environmental factors. The microbiome contributes to CeD pathophysiology modulating the immune response by the action of short-chain fatty acids (SCFA), affecting gut barrier integrity allowing the entrance of gluten derived proteins, and degrading immunogenic peptides of gluten through endoprolyl peptidase enzymes. Results: We reviewed state of the art in taxonomic composition for CeD and compiled the larger dataset of 16S prokaryotic ribosomal RNA (rRNA) gene high-throughput sequencing for consensus profiling. We present for the first time an integrative analysis of metataxonomic data from CeD patients, including samples from different body sites (saliva, pharynx, duodenum, and stool). We found the presence of coordinated changes through the gastrointestinal tract characterised by an increase in Actinobacteria species in the upper tract (pharynx and duodenum), and an increase in Proteobacteria in the lower tract (duodenum and stool), as well as site-specific changes evidencing a dysbiosis in CeD patients' microbiota. Moreover, we described the effect of adherence to a gluten-free diet (GFD) evidenced by an increase in beneficial bacteria and a decrease in some Betaproteobacteriales but not fully restoring CeD-related dysbiosis. Conclusions: We illustrate that the gut microbiota acts as an enhancer of immune response in CeD through the production of lipopolysaccharides and other bacterial components that activate the immune response and by decrease SCFA producers bacteria. Furthermore, microbial changes observed through the gastrointestinal tract of CeD patients may help manage the disease and follow-up GFD treatment.

Dysbiosis of the microbiome has been related to the Celiac disease (CeD) progress, an autoimmune disease characterised by gluten intolerance developed in genetically susceptible individuals under certain environmental factors. The microbiome contributes to CeD pathophysiology modulating the immune response by the action of short-chain fatty acids (SCFA), affecting gut barrier integrity allowing the entrance of gluten derived proteins, and degrading immunogenic peptides of gluten through endoprolyl peptidase enzymes. We reviewed state of the art in taxonomic composition for CeD and compiled the larger dataset of 16S prokaryotic ribosomal RNA (rRNA) gene high-throughput sequencing for consensus profiling. We present for the first time an integrative analysis of metataxonomic data from CeD patients, including samples from different body sites (saliva, pharynx, duodenum, and stool). We found the presence of coordinated changes through the gastrointestinal tract characterised by an increase in Actinobacteria species in the upper tract (pharynx and duodenum), and an increase in Proteobacteria in the lower tract (duodenum and stool), as well as site-specific changes evidencing a dysbiosis in CeD patients' microbiota. Moreover, we described the effect of adherence to a gluten-free diet (GFD) evidenced by an increase in beneficial bacteria and a decrease in some Betaproteobacteriales but not fully restoring CeD-related dysbiosis. We illustrate that the gut microbiota acts as an enhancer of immune response in CeD through the production of lipopolysaccharides and other bacterial components that activate the immune response and by decrease SCFA producers bacteria. Furthermore, microbial changes observed through the gastrointestinal tract of CeD patients may help manage the disease and follow-up GFD treatment.